Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiner, S
Right arrow Articles by Horvitz, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiner, S
Right arrow Articles by Horvitz, C
American Journal of Health-System Pharmacy, Vol 58, Issue 2, 146-150
Copyright © 2001 by American Society of Health-System Pharmacists

Articles

Beyond pharmaceutical manufacturer assistance: broadening the scope of an indigent drug program

S Weiner, J Dischler, and C Horvitz


A medication assistance program at a university medical center is described. The program was implemented in July 1999 by the ambulatory care pharmacy at the University of Illinois at Chicago Medical Center (UICMC). A full-time pharmacist and a full-time social worker run the program, along with support from technicians and a student extern. The program functions like a clinic, with both scheduled appointments and drop-ins. Patients are referred by UICMC providers or may self-refer. Sources of assistance include Medicaid, Medicare Part B, several state programs, manufacturers' programs, drug samples, private insurance plans and HMOs, and the patients themselves in the form of small payments. Patients receive medications at UICMC's expense only as a last resort. The medication assistance program helped 231 patients in the six months from July to December 1999. Program costs totaled $110,537, but $237,985 was saved. Only 13% of the savings came from pharmaceutical companies; 63% came from Medicaid. Experience with the program suggests that medication assistance initiatives should be structured to tap the full spectrum of resources for indigent patients, that programs be staffed by personnel with relevant experience, that program staff be prepared to work closely with patients and to follow up, and that the institution's charitable goods and services be restricted to patients for whom there are no other resources. A highly proactive medication assistance program at a university medical center improves the access of indigent patients to medications and is cost-effective.
 



This article has been cited by other articles:


Home page
 Am J Health Syst PharmHome page
D. Chauncey, C. D. Mullins, B. V. Tran, D. McNally, and R. N. McEwan
Medication access through patient assistance programs.
Am. J. Health Syst. Pharm., July 1, 2006; 63(13): 1254 - 1259.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
M. W. Strum, R. Hopkins, D. S. West, and B. N. Harris
Effects of a medication assistance program on health outcomes in patients with type 2 diabetes mellitus
Am. J. Health Syst. Pharm., May 15, 2005; 62(10): 1048 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
K. S. Duke, K. Raube, and H. L. Lipton
Patient-assistance programs: Assessment of and use by safety-net clinics
Am. J. Health Syst. Pharm., April 1, 2005; 62(7): 726 - 731.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Health-System Pharmacists.